My watch list
my.chemeurope.com  
Login  

Epzicom



Epzicom is the brand name for a pharmaceutical treatment for HIV infection. It is a fixed dose combination of lamivudine (3TC, Epivir) and abacavir (ABC, Ziagen). The combination of the two drugs has a stronger effect than either drug alone.[citation needed]

Additional recommended knowledge

Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).


It was approved by the FDA on August 2, 2004. It is marketed by GlaxoSmithKline. It is also sold in other countries as Kivexa®

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Epzicom". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE